A Phase 1 Trial of the p97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas

Conditions: Advanced Solid Tumors; Advanced Lymphomas
Intervention: Drug: CB-5339
Sponsor: National Cancer Institute (NCI)
Not yet recruiting

Pub Date:

Monday, June 29, 2020 - 9:00am

Study URL:

https://clinicaltrials.gov/ct2/show/NCT04449562?term=genomics%20DNA&%3Brecrs=abc

You are here

A Phase 1 Trial of the p97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas